AzTrials
AzTrials

Growth; Stunting, NutritionalINFERNCT06578338

Assessing a Height Artificial Intelligence Algorithm to Estimate Height of Children

An observational study of Growth; Stunting, Nutritional, run by Danone Asia Pacific Holdings Pte, Ltd. at 1 site in Singapore.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

An exploratory study to explore the possibility of using computer vision algorithms to estimate a child's height using images taken by a healthcare professional or parents. Read more about this study

Who is it for?
Ages 24 months to 6 yearsHealthy volunteers can take part
Conditions the study is for
Growth; Stunting, Nutritional
What is being tested?
Physical height measurement
How many people
250 participants
Where
1 siteSingapore
Study dates
9 Sep 2024to 4 Mar 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 24 months to 6 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Children aged above 24 months old and below 6 years of age with no physical deformities

Who may be able to join

  • Children aged above 24 months old and below 6 years old.
  • Parent(s) should have access to the internet and a smartphone or table to complete study questionnaires, take images and upload images.
  • Parent(s) should be able to comprehend the content of the study and complete the study questionnaires in English.
  • Written consent from parents and/or legally acceptable representative

Who cannot join

  • Children who are unable to stand upright against a wall
  • Children who are unable to cooperate with standing height measurement

Trial locations and contacts

1 site in 1 country.

Singapore1 site
  • KK Women's and Children's Hospital

    Singapore

Other trials in Singapore

About this study

Official title: A Study to Collect Data to Build Artificial INtelligence Derived Algorithms For Estimating Height and Weight in childRen (INFER)

An exploratory study to explore the possibility of using computer vision algorithms to estimate a child's height using images taken by a healthcare professional or parents.

Read the detailed description

This is an exploratory, observation, data-collection study that aims to evaluate the performance of a Height Artificial Intelligence (HAI) algorithm in a real world setting. Images will be collected by parents or healthcare professionals, together with physical height measurements. This data will be used to evaluate the accuracy of the algorithm and to explore potential improvements. Data on the acceptance and experience of using the algorithm will be collected for improvements.

Being tested
Physical height measurement
Keywords
Growth, Height, Artificial Intelligence, Algorithm
Medical subject headings
Growth Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical height measurementOther

    Physical height will be measured and images will be collected for AI to estimate the height

Study groups in NCT06578338
Study groupRoleWhat they receive
Children aged above 24 months old and below 6 years of ageChildren aged above 24 months old and below 6 years of age with no structural abnormalities of the lower limbs or orthopaedic conditions
Receives: Other: Physical height measurement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy of the height AI (cm)

    Accuracy of the Height AI (cm) in a clinic and in a home setting, derived from:

    1. The height AI prediction from images collected
    2. The physical height measurements of subjects using WHO standard height measurement

    Measured: 2 days

Secondary outcomes (1)
  1. Accuracy of the Weight AI (kg)

    Accuracy of the Weight AI (kg) in a clinic and in a home setting, derived from:

    1. The weight prediction from the standing images collected in this study
    2. The WHO standard weight measurement of subjects

    Measured: 2 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Aug 2024
  2. Study start9 Sep 2024
  3. Primary completion4 Mar 2025
  4. Study completion4 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
250 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06578338
Sponsor's protocol ID
SBB20R&31696-A
Acronym
INFER
Status last verified
Feb 2026
First submitted
5 Aug 2024
Last updated
4 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Yap F, Lee YS, Aw MMH. Growth Assessment and Monitoring during Childhood. Ann Acad Med Singap. 2018 Apr;47(4):149-155.

    PubMed 29777245
  • Schmidhuber J. Deep learning in neural networks: an overview. Neural Netw. 2015 Jan;61:85-117. doi: 10.1016/j.neunet.2014.09.003. Epub 2014 Oct 13.

    PubMed 25462637

Questions about this trial

What is this clinical trial studying?

An observational study of Growth; Stunting, Nutritional, run by Danone Asia Pacific Holdings Pte, Ltd. at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy of the height AI (cm) (time frame: 2 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06578338, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in